Neointimal smooth muscle cells display a proinflammatory phenotype resulting in increased leukocyte recruitment mediated by P-selectin and chemokines

Circ Res. 2004 Apr 2;94(6):776-84. doi: 10.1161/01.RES.0000121105.72718.5C. Epub 2004 Feb 12.

Abstract

Leukocyte recruitment is crucial for the response to vascular injury in spontaneous and accelerated atherosclerosis. Whereas the mechanisms of leukocyte adhesion to endothelium or matrix-bound platelets have been characterized, less is known about the proadhesive role of smooth muscle cells (SMCs) exposed after endothelial denudation. In laminar flow assays, neointimal rat SMCs (niSMCs) supported a 2.5-fold higher arrest of monocytes and "memory" T lymphocytes than medial SMCs, which was dependent on both P-selectin and VLA-4, as demonstrated by blocking antibodies. The increase in monocyte arrest on niSMCs was triggered by the CXC chemokine GRO-alpha and fractalkine, whereas "memory" T cell arrest was mediated by stromal cell-derived factor (SDF)-1alpha. This functional phenotype was paralleled by a constitutively increased mRNA and surface expression of P-selectin and of relevant chemokines in niSMCs, as assessed by real-time PCR and flow cytometry. The increased expression of P-selectin in niSMCs versus medial SMCs was associated with enhanced NF-kappaB activity, as revealed by immunofluorescence staining for nuclear p65 in vitro. Inhibition of NF-kappaB by adenoviral IkappaBalpha in niSMCs resulted in a marked reduction of increased leukocyte arrest in flow. Furthermore, P-selectin expression by niSMCs in vivo was confirmed in a hypercholesterolemic mouse model of vascular injury by double immunofluorescence and by RT-PCR after laser microdissection. In conclusion, we have identified a NF-kappaB-mediated proinflammatory phenotype of niSMCs that is characterized by increased P-selectin and chemokine expression and thereby effectively supports leukocyte recruitment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aorta, Thoracic / injuries
  • Apolipoproteins E / deficiency
  • Apolipoproteins E / genetics
  • Arteriosclerosis / metabolism
  • Arteriosclerosis / pathology
  • Cell Adhesion
  • Cells, Cultured / drug effects
  • Cells, Cultured / metabolism
  • Chemokine CX3CL1
  • Chemokines, CX3C / pharmacology
  • Chemotaxis, Leukocyte / physiology*
  • Constriction, Pathologic
  • Cytokines / biosynthesis
  • Cytokines / genetics
  • Cytokines / physiology
  • Endothelium, Vascular / injuries
  • Gene Expression Regulation
  • Hypercholesterolemia / metabolism
  • I-kappa B Proteins / physiology
  • Inflammation / metabolism
  • Inflammation / pathology*
  • Integrin alpha4beta1 / biosynthesis
  • Integrin alpha4beta1 / genetics
  • Integrin alpha4beta1 / physiology*
  • Membrane Proteins / pharmacology
  • Mice
  • Mice, Knockout
  • Monocytes / cytology
  • Muscle, Smooth, Vascular / cytology
  • Muscle, Smooth, Vascular / metabolism*
  • Myocytes, Smooth Muscle / metabolism*
  • NF-KappaB Inhibitor alpha
  • NF-kappa B / physiology*
  • P-Selectin / biosynthesis
  • P-Selectin / genetics
  • P-Selectin / physiology*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Interleukin-8B / physiology
  • Recombinant Fusion Proteins / physiology
  • Recurrence
  • Rheology
  • T-Lymphocyte Subsets / cytology

Substances

  • Apolipoproteins E
  • Chemokine CX3CL1
  • Chemokines, CX3C
  • Cx3cl1 protein, mouse
  • Cx3cl1 protein, rat
  • Cytokines
  • I-kappa B Proteins
  • Integrin alpha4beta1
  • Membrane Proteins
  • NF-kappa B
  • Nfkbia protein, mouse
  • Nfkbia protein, rat
  • P-Selectin
  • Receptors, Interleukin-8B
  • Recombinant Fusion Proteins
  • NF-KappaB Inhibitor alpha